A 68-year-old man with COPD (FEV₁ 35% predicted) presents with a 3-day history of productive cough with purulent sputum, fever (38.5°C), and dyspnea. He lives in the community and has not been hospitalized in the past year. Chest X-ray shows a left lower lobe consolidation. Blood culture is pending. Sputum Gram stain shows gram-negative rods. Which organism is most likely responsible, and what is the most appropriate empiric antibiotic regimen?

Explanation

## Clinical Diagnosis **Key Point:** The combination of COPD, gram-negative rods on sputum Gram stain, and community-onset presentation points to *Klebsiella pneumoniae* as the most likely pathogen in this CAP scenario. ## Organism Identification | Feature | *K. pneumoniae* | *P. aeruginosa* | *H. influenzae* | *S. pneumoniae* | | --- | --- | --- | --- | --- | | Gram stain | Gram-negative rod | Gram-negative rod | Gram-negative coccobacillus | Gram-positive diplococcus | | CAP in COPD | Common | Rare (HAP/VAP) | Common | Most common | | Blood culture positivity | 10–15% | Rare in CAP | Rare | 20–30% | | Risk factors | Alcoholism, diabetes, COPD | Hospitalization, mechanical ventilation | COPD, smoking | Age, asplenia, immunosuppression | **High-Yield:** *Klebsiella* is the most common gram-negative rod causing CAP, especially in patients with COPD, alcoholism, or diabetes. It produces a characteristic mucoid, blood-tinged sputum ("currant jelly") and often causes necrotizing pneumonia with abscess formation. ## Antibiotic Selection for CAP with COPD **Clinical Pearl:** In CAP with COPD and gram-negative rods, empiric coverage must include: - 3rd-generation cephalosporin (ceftriaxone, cefotaxime) OR - Fluoroquinolone (levofloxacin, moxifloxacin) Ceftriaxone and fluoroquinolones provide excellent lung penetration and cover *Klebsiella*, *H. influenzae*, and *S. pneumoniae* simultaneously. **Warning:** Piperacillin-tazobactam and carbapenems are reserved for **HAP/VAP** (hospital-acquired or ventilator-associated pneumonia) where *Pseudomonas* coverage is mandatory. This patient has community-onset CAP, not HAP. **High-Yield:** *Pseudomonas aeruginosa* is NOT a typical CAP pathogen unless the patient has: - Recent hospitalization or ICU stay - Mechanical ventilation - Cystic fibrosis - Severe immunosuppression This patient meets none of these criteria. ## Why Ceftriaxone or Fluoroquinolone? 1. **Broad spectrum:** Covers gram-positive (*S. pneumoniae*) and gram-negative (*Klebsiella*, *H. influenzae*) organisms 2. **Lung penetration:** Excellent intracellular and alveolar concentrations 3. **Mortality data:** Guideline-recommended for CAP with COPD 4. **No resistance concerns:** Unlike amoxicillin-clavulanate, which is inadequate for gram-negative CAP [cite:Harrison 21e Ch 297]